Cancer Cell International

OCT 8, 2026 · JOURNAL ARTICLE

Metadherin at the invasive front drives OSCC via selective KRT14 regulation

Cancer Cell International

Despite advances in multimodal therapy, effective treatments for aggressive oral squamous cell carcinoma (OSCC) remain limited, underscoring the need for actionable therapeutic tar

OCT 6, 2026 · JOURNAL ARTICLE

Cancer-associated fibroblasts as key mediators of therapeutic resistance and tumor progression in colorectal cancer

Cancer Cell International

Abstract Background Cancer-associated fibroblasts (CAFs) are instrumental in tumor progression by interacting with tumor cells, other stromal components, and the extracellular matr

OCT 6, 2026 · JOURNAL ARTICLE

BH3 mimetics sensitize bladder cancer cells to cisplatin treatment

Cancer Cell International

Muscle-invasive bladder cancer is most often treated with radical surgery and perioperative cisplatin-based chemotherapy, this represents a challenge for patient survival due to ci

SEP 29, 2026 · JOURNAL ARTICLE

Cold atmospheric plasma treated medium (PTM) induce antitumor effects in human ovarian cancer cells

Cancer Cell International

Abstract Plasma treated solutions (PTS) have emerged as a promising anticancer strategy due to their ability to generate reactive oxygen and nitrogen species (RONS) that induce oxi

SEP 21, 2026 · JOURNAL ARTICLE

Fibroblast-associated migrasome programs define TSPAN4-driven progression and clinical risk stratification in gastric cancer

Cancer Cell International

Gastric cancer (GC) is a highly aggressive malignancy with poor prognosis, characterized by complex tumor microenvironment (TME) interactions. Migrasomes have been implicated in ca

SEP 17, 2026 · JOURNAL ARTICLE

Enhanced survival through repeated photodynamic therapy and almost complete tumor regression by prior radiation therapy in an orthotopic rat bladder cancer model

Cancer Cell International

Abstract Introduction The development of new organ-preserving treatment alternatives is still an important issue in bladder cancer (BCa) research. A combination of minimally-invasi

SEP 10, 2026 · JOURNAL ARTICLE

ECT2 antagonizes lipoic acid to modulate papillary thyroid carcinoma progression through energy metabolism pathways

Cancer Cell International

Mechanistic in vitro study in cell lines with RNA sequencing showing ECT2's role in PTC proliferation and drug resistance; lacks in vivo validation, clinical trial data, or prospective patient outcomes.

SEP 7, 2026 · JOURNAL ARTICLE

Immunogenic and systemic antitumor responses induced by photodynamic therapy: a systematic review of the abscopal effect

Cancer Cell International

This systematic review of preclinical animal models raises mechanistic questions about PDT's potential to trigger systemic immunity but does not provide clinical evidence sufficient to guide practice or confirm efficacy in humans.